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This report describes a novel, one-pot synthesis of hybrid nanoparticles formed by a nanostructured
inorganic silica core and an organic pH-responsive hydrogel shell. This easy-to-perform, oil-in-water
emulsion process synthesizes ﬂuorescently-doped silica nanoparticles wrapped within a tunable coating
of cationic poly(2-diethylaminoethyl methacrylate) hydrogel in one step. Transmission electron micro-
scopy and dynamic light scattering analysis demonstrated that the hydrogel-coated nanoparticles are
uniformly dispersed in the aqueous phase. The formation of covalent chemical bonds between the silica
and the polymer increases the stability of the organic phase around the inorganic core as demonstrated
by thermogravimetric analysis. The cationic nature of the hydrogel is responsible for the pH buffering
properties of the nanostructured system and was evaluated by titration experiments. Zeta-potential
analysis demonstrated that the charge of the system was reversed when transitioned from acidic to
basic pH and vice versa. Consequently, small interfering RNA (siRNA) can be loaded and released in an
acidic pH environment thereby enabling the hybrid particles and their payload to avoid endosomal
sequestration and enzymatic degradation. These nanoparticles, loaded with speciﬁc siRNA molecules
directed towards the transcript of the membrane receptor CXCR4, signiﬁcantly decreased the expression
of this protein in a human breast cancer cell line (i.e., MDA-MB-231). Moreover, intravenous adminis-
tration of siRNA-loaded nanoparticles demonstrated a preferential accumulation at the tumor site that
resulted in a reduction of CXCR4 expression.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
New trends in polymer science have led to the development of
materials responsive to the physical and chemical stimuli of the
biological environment [1,2]. Polymeric “smart” hydrogels have
been designed that can swell [3], dissolve [4], and release [1,5] ave Medicine: Center for Bio-
itute, 6670 Bertner Ave., MS
E. Tasciotti).
Ltd. This is an open access article utherapeutic payload in response to ﬂuctuations in biological tem-
perature and pH. Nanoscale, pH-responsive hydrogel particles are
considered as promising drug delivery platforms due to their ability
to release a payload in a timely fashion by responding to physio-
logical changes of the microenvironment [1,2,6]. This approach has
signiﬁcant potential in improving the use of small interfering RNA
(siRNA) as a therapeutic agent by protecting them from intracel-
lular nucleases foundwithin the acidic endolysosomal vesicles [2,7]
and favor their release in the cell cytoplasm after internalization.
However, the use of a hydrogel matrix as a drug delivery vehicle is
limited by its low structural integrity and poor mechanical stability
[8]. Furthermore, although the mechanical properties of hydrogelsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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this also can affect its environmental responsiveness and biocom-
patibility [9]. For example, pH-responsive hydrogels have been
demonstrated to swell within a speciﬁc pH range, however, when
such polymers are synthesized with an increased crosslinking
density, they tend to swell less and particularly in more extreme pH
conditions [10e15].
The immunogenic properties of hydrogels largely depend on
their speciﬁc and qualitative composition rather than on their de-
gree of crosslinking, thus themajority of polymeric smart hydrogels
display little or no immunogenicity [16e21]. On the other hand, a
high degree of crosslinking may affect the cytotoxicity of these
polymers [3,9,22]. In most cases, the crosslinking process involves
the free radical polymerization of short cross-linkers with a poly-
mer chain. Unreacted free radicals that remain in the polymer
network may adversely affect the cytocompatibility of the polymer
system [9,23]. These limitations can be overcome by developing a
hybrid system based on the incorporation of a rigid inorganic core
with a minimally crosslinked soft hydrogel matrix. The inorganic
core stabilizes the hybrid systemwhile the hydrogel matrix retains
the environmental sensitivity [8,24].
The synthesis of pH-responsive hybrid nanoparticle delivery
platforms is typically based on coating the particle surface with
poly(ethyleneimine) [4], poly(methacrylic acid) [1], or poly(2-
diethylaminoethyl methacrylate) (PDEAEM) [25e27]. Synthesis
usually entails a lengthy, multistep process consisting of: particle
synthesis, surface modiﬁcation with a chemical linker, hydrogel
coating, and labeling with a ﬂuorescent tag [25,28]. Herein, we
describe a one-pot, oil-in-water emulsion synthesis process for
hybrid, monodispersed, pH-responsive, ﬂuorescent nanoparticles
capable of: (i) protecting a siRNA payload from the extracellular and
intracellular microenvironment; (ii) escaping together with their
payload from endosomal vesicles, and (iii) releasing the siRNA
cargo into the cytoplasmwhere it can efﬁciently exert its biological
action in vitro and in vivo.
2. Results and discussion
2.1. Synthesis of the hybrid nanoparticles
We have developed a novel one-pot synthesis approach to
produce hybrid nanoparticles (HNP). We applied a self-assembly
covalent stabilization strategy to produce a nanoscale single par-
ticle as a sphere with a coreeshell morphology. This one-pot pro-
cedure is based on the free radical co-polymerization of the cationic
monomer 2-(diethylamino)ethyl methacrylate (DEAEM) and the
monomeric silica precursor vinyltrimethoxysilane (VTMS) in the
presence of polyethylene glycol methacrylate (PEGMA) and tri-
ethylene glycol dimethacrylate (TEGDMA) linkers. This procedure
yielded the in-situ formation of a cross-linked PDEAEM hydrogel
shell around the silica nanoparticle (SNP) core (Fig. 1a). The
resulting HNP consisted of a system able to buffer and swell in
acidic pH. Scanning electron micrographs revealed that the HNP
surface was rougher than the SNP surface (Fig. 1b), while trans-
mission electron micrographs conﬁrmed the presence of a
distinctive 10 nm polymer layer surrounding the silica core (Fig.1c).
2.2. Physicochemical characterization of the hybrid nanoparticles
The Fourier transform infrared spectroscopy (FTIR) analysis of
the HNP conﬁrmed the formation of chemical bonds between
PDEAEM and silica (Fig. 2a). The infrared bands at 1135 cm1 and
1702 cm1 on the spectrum of the pristine hydrogel correspond to
the CeN stretch of the tertiary amine and the C]O stretch of the
PDEAEM carbonyl group, respectively [29,30]. The HNP spectrumshowed a band at 1080 cm1 (Fig. 2a) that represents an oxygen-
silicon-oxygen (OeSieO) bond, as well as a band at 1451 cm1
that represents the asymmetric distortion vibration of the SieC
bond [26,28]. Moreover, a comparison between the FTIR spectra of
the DEAEM monomer, the VTMS monomer and the HNP (Fig. 2b)
demonstrated polymerization between the two monomers. The
disappearance of the peaks that correspond to the unsaturated
bond (C]C) of the VTMS and PDEAEM in the infrared spectrum of
the HNP suggests that in this hybrid system, the silica was bound to
the polymeric hydrogel through a CeC covalent linker that resulted
from the polymerization of vinyl-terminated VTMS (C]C) with
PDEAEM [31,32].
The hydrogel:silica ratio was evaluated by thermogravimetric
analysis [33]. The HNP, when heated to 700 C, displayed an average
weight loss of 25% (Fig. 2c). Conversely, pristine polymer heated to
the same temperature completely decomposed, while the weight
loss of the SNP was negligible. Also, the onset degradation tem-
perature of the HNP was higher than that of pristine polymer
(DT ¼ ~40 C). This was likely due to the enhanced adhesion be-
tween the polymer chain and silica particles which acted as a
barrier to the volatile materials and increased the HNP thermal
stability [34,35].
We also evaluated the HNP surface structure using X-ray
photoelectron spectroscopy (XPS). The wide-scan XPS spectrum of
the hybrid surface (Fig. 2d) shows the peaks corresponding to
carbon, oxygen, nitrogen and silicon atoms at characteristic binding
energies. Fig. 2e illustrates the C1s core level spectra, deconvoluted
into three component peaks (i.e., A, B, C). The intensity ratios of
these deconvoluted peaks are in agreement with the stoichiometric
carbon atoms in the chemical structure of PDEAEM as
[A]:[B]:[C] ¼ 5:3:1 (see Fig. 2f). These results conﬁrm that the
grafted polymer layer on the silica surface is composed of PDEAEM
chains.
We next evaluated the polydispersity of the HNP in aqueous
media using dynamic light scattering (DLS) [36] analysis (poly-
dispersity index 0.204, Fig. 2g) and transmission electron micro-
scopy (TEM) (Fig. 2h). These experiments showed that the particles
were uniformly dispersedwhen placed in an aqueous environment.
2.3. pH-responsiveness of the hybrid nanoparticles
To determine pH-responsiveness, we studied a suspension of
0.1 mg mL1 HNP at different pH values using DLS. This analysis
demonstrated that the solvated hydrodynamic diameter (Dh) of the
HNPwas inversely dependent on the environmental pH (i.e., the Dh
increased as pH decreased) (Fig. 3a). In an acidic environment, the
tertiary amine group of the PDEAEM shell is protonated, causing
the shell to acquire a positive charge as previously reported [37].
The strong chain-solvent interactions and inter-molecule electro-
static repulsion induced polymer chain stretching and increased Dh
(as schematically shown in Fig. 1a). This caused the hydrodynamic
volume of the HNP to increase from 0.5 106 nm3 to 8.6  106 nm3
as the environmental pH changed from 7 to 5, resulting in a 17-fold
increase in hydrodynamic volume (Fig. 3a,b). However, in neutral
and alkaline conditions, the PDEAEM chains were deprotonated,
thereby becoming hydrophobic and contracting against the surface
of the silica core [38,39]. This contraction favored the creation of
polymer chainechain interactions, which being stronger than
chain-solvent interactions, induced chain aggregation and
decreased the HNP Dh at physiological and alkaline pH (Fig. 3a). As
expected, the analysis of the Dh as a function of the pH revealed a
sigmoidal pattern during the HNP transition from a collapsed state
to a swollen state [26,37]. Zeta potential analysis conﬁrmed the
protonation of the nanogel coating as witnessed by a progressive
shift towards a positive charge, shifting the pH towards acidic
Fig. 1. (a) Schematic representation of hybrid nanoparticle (HNP) synthesis and pH-responsiveness; (b) SEM images of silica nanoparticles (SNP) and HNP, respectively; (c) TEM
images of SNP and HNP, respectively.
Fig. 2. Chemico-physical characterization of the HNP. (a) Fourier transform infrared (FTIR) spectroscopy study of the HNP and pristine polymer. (b) FTIR study of the polymerization:
HNP, DEAEM monomer and monomeric silica precursor VTMS. (c) Thermogravimetric analysis of the SNP, HNP and of the pristine polymer. XPS analysis: (d) XPS survey spectrum;
(e) C1s core level spectrum of the HNP surface deconvoluted into the three component peaks (A, B and C) relative to the three types of carbon atoms. (f) Labeling of the different
carbon moieties in the PDEAEM molecule. Dispersion study of the HNP: (g) Dynamic light scattering study; (h) TEM analysis (inset shows a single particle).
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Fig. 3. pH responsiveness study of the HNP: (a) hydrodynamic diameter (Dh) and (b) volume of the nanogel particles in varying pH environments; (c) surface zeta-potential of the
HNP in varying pH environments. (d) Reversible response of the HNP with varying pH. (e) Dh of the HNP synthesized by using two different monomer-to-precursor ratios. Titration
study of the HNP: (f) decreasing pH proﬁles of the experimental and control suspensions; (g) volume of HCl required to decrease the pH from 7.1 to 4.1 in the experimental and
control suspensions.
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solvated ion (Hþ) at pH values below 7 [26]. Moreover, the HNP
underwent a reversible swellingeshrinking cycle as the pH
decreased from 7 to 4. The swelling ratio of the HNP remained
almost constant with a 10% loss of polymer at the end of the third
cycle, likely as a consequence of the increased solubility of PDEAEM
in the acidic environment (Fig. 3d).
To evaluate the tunability of our system, we synthesized HNP
with varying thicknesses of polymer coating. HNP pH-dependent
swelling was directly correlated with the amount of PDEAEM
bound on the surface of the silica core (Fig. 3e). This observation
indicates that the hydrogel coating functioned as an on-off switch,
linked to the transition from neutral to acidic environments, and
that the swelling, as a result of pH, can be tailored by regulating the
copolymer ratio and coating thickness.
Additionally, protonation of HNP has been shown to produce a
buffering effect on the surrounding environment [40,41]. We
assessed this activity by titrating a basic aqueous solution of 0.1 M
NaCl (solvent) with 0.1 M HCl, with and without HNP. Compared to
the solvent, the presence of the HNP resulted in a slower decrease
of the pH below 7 (Fig. 3f) and required a larger volume of HCl to
decrease the pH of the solution from 7.1 to 4.1 (Fig. 3g). The HNP net
buffering capacity was 11.0 which represents the mmol of Hþ
required to decrease the pH of 1 mg mL1 of suspension from 7.1 to
4.1 [42].
These results are in agreement with those reported by Peppas
and colleagues [26,43], who demonstrated that PDEAEM has a pKa
of about 7.2. Therefore the buffering properties of this polymer can
exploit the endosomal acidic environment (pH < 7.2). In addition,
these results strongly suggest that the hybrid nanogel prevented
acidiﬁcation of the suspension by chelating Hþ ions. This process,
known as the “proton sponge effect”, has been shown to favor the
escape of nanoparticles from endosomal vesicles [39,44,45].2.4. siRNA loading and release
Loading of siRNA was driven via the electrostatic interaction
between the negatively charged molecules of nucleic acid and thepositive charge of the HNP polymer shell. The measurement of the
surface charge of the HNP revealed that the particles maintained a
positive surface charge at pH 6 and 7, whereas a negative charge
was recorded at pH 8 (Fig. 4a). Conversely, free siRNA displayed a
negative surface charge throughout all pH conditions (Fig. 4a) and
resulted in a slight pH shift when loaded within the HNP. We next
evaluated the loading efﬁciency of the siRNA molecules in acidic
and physiological pH conditions, and obtained a loading efﬁciency
of 95% at pH 6 compared to 70% at pH 7.4 (Fig. 4b). This difference
was likely due to the higher afﬁnity the particles had for siRNA as a
direct result of polymer protonation in acidic conditions. Therefore,
in the subsequent experiments, the siRNAwas loaded into the HNP
only at pH 6.
The release of siRNA was investigated in physiologic and acidic
conditions. After 4 h of incubation, the cumulative siRNA release
from the siRNA-HNP reached ~80% at pH 6 with a 53% release at pH
7.4 (Fig. 4c). Despite the higher afﬁnity of the HNP for the payload,
siRNA release was accelerated in acidic conditions likely as a result
of hydrogel swelling (Fig. 3a), thereby increasing the solubility of
the coating and favoring the diffusion of the payload into the sur-
rounding environment. Conversely, the release of siRNA was
reduced in physiological pH even though the afﬁnity of the HNP for
siRNA was lower in this environmental condition. We assume that
the entrapment of siRNA in the collapsed hydrogel structure
delayed the release of siRNA molecules in the presence of physio-
logic pH.2.5. Biological effects of the hybrid nanoparticles
2.5.1. Cytotoxicity and endolysosomal effect of the HNP
To evaluate the ability of the HNP to deliver a bioactive payload,
we used a human breast cancer cell line, MDA-MB-231. The effect of
particles on cell viability was assessed using a (3-(4,5-
dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide) (MTT)
assaywhich showed that both SNP and HNP had a negligible impact
at concentrations of 0e2 ng cell1 (Fig. 5a,b).
The endolysosomal function of MDA-MB-231 cells exposed to
HNP, at doses ranging from 0.5 ng cell1 to 2 ng cell1, was
Fig. 4. siRNA loading and release. (a) Surface z-potential analysis of siRNA and the HNP at different pH values before and after loading. (b) Loading of siRNA at pH 6 and 7.4. (c)
Release of siRNA from the HNP at pH 6 and 7.4.
Fig. 5. Evaluation of the impact of the SNP and HNP on cell viability measured by MTT assay at 3 h (a) and 24 h (b). The data are normalized against untreated control cells. In the
concentration range and time points tested, the effect of the SNP and HNP on cell viability did not exceed 20%. Evaluation of neutral red dye uptake in endolysosomal vesicles at 3 h
(c) and 24 h (d) after treatment with the SNP and HNP. The data are normalized against untreated control cells. The HNP greatly impaired the ability of lysosomal vesicles to retain
this viable dye 3 h after treatment. Error bars represent standard deviation (n ¼ 6)
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red dye into the endolysosomal vesicles [46,47]. As expected, the
HNP impaired the ability of the endosomal compartment to retain
the dye. In particular, 3 h after treatment, the HNP reduced endo-
somal function, probably as a consequence of the “proton sponge
effect” (Fig. 5c). The ability to incorporate the dye into the intra-
cellular acidic vesicles was restored 24 h after treatment with the
lowest concentrations of HNP (0.5e1.5 ng cell1), whereas this
ability was still impaired 24 h after treatment with 2 ng cell1 of
HNP (Fig. 5d). Taken together, these results suggest that high doses
of HNP do not affect MDA-MB-231 cell viability, associated with
brief obstruction of endosomal cell functions likely attributed to the
disruption of endosomal vesicles.
To further evaluate the potential of these HNP to escape endo-
lysosomal compartments, we analyzed cells treated with HNP, SNP,
and untreated cells by TEM (Fig. 6). Cells were analyzed 3 h after
treatment with 0.3 ng cell1 of particles, a dose that did not cause
any cytotoxic effect (Fig. 5a), while the same dose caused the loss of
neutral red uptake (Fig. 5c). TEM images showed that untreated and
SNP-treated cells maintained distinguishable vesicles as demon-
strated by a regular, round shape delimited by a compact border.Conversely, cells treated with HNP contained subcellular structures
that resembled vesicular or vacuolar organelles, although these
structures were irregular in shape and had a smooth, non-
continuous border. Additionally, the SNP tended to remain group-
ed and were clearly conﬁned to vesicular structures that had rela-
tively compact borders (Fig. 6) while the HNP were scattered
throughout the cytoplasm. These observations suggest that the
HNP broke out from endolysosomal vesicles and, at least partially,
compromised the normal intracellular vesicle trafﬁcking.
2.5.2. siRNA intracellular delivery
To evaluate the efﬁciency of the HNP inmediating siRNA cellular
internalization, we performed a ﬂuorescence microscopy analysis
on MDA-MB-231 cells after internalization of ﬂuorescently labeled
siRNA either delivered by HNP or transfected using a commercial
liposomal transfection reagent. The HNP were loaded with the
same amount of siRNA (0.166 pmol siRNA g1 HNP; 0.3 ng particle
cell1; 5  102 fmol siRNA cell1) that was used for transfection
with reagent (5  102 fmol siRNA cell1). This analysis revealed
that the efﬁciency of the HNP in mediating siRNA cellular inter-
nalization was similar to that of the transfection reagent (Fig. 7a).
Fig. 6. TEM images of MDA-MB-231 cells 3 h after treatment with HNP. SNP-treated and untreated (CTRL) cells served as a control.
Fig. 7. (a) Fluorescent microscopy analysis of MDA-MB-231 cells shows that the intracellular delivery of Cy3-labeled siRNA (red) mediated by FITC-labeled HNP (green) has an
efﬁciency comparable to that of transfection. Error bars represent standard deviations (n ¼ 16). Evaluation of CXCR4 silencing in MDA-MB-231 cells 48 h after treatment: (b) Real-
time RT-qPCR analysis of gene expression and (c) Western blot analysis of protein levels. siRNA-loaded HNP effectively decreased the expression of CXCR4 mRNA and protein. Error
bars represent standard deviation (n ¼ 3). * ¼ p < 0.01 (compared to Control). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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treating the cells with siRNA-loaded HNP (3.3 pmol siRNA mg1
HNP; 0.3 ng HNP cell1) directed against CXCR4 mRNA (which
encodes a chemokine receptor) [48] compared to HNP alone and
scrambled siRNA-loaded HNP as negative controls. The expression
levels of the CXCR4 gene and protein were analyzed 48 h after
treatment using real-time qPCR and Western blot (Fig. 7b and c,respectively). CXCR4 siRNA-loaded HNP signiﬁcantly reduced the
expression of both the CXCR4 transcript and protein. Moreover, the
silencing efﬁcacy of siRNA-loaded HNP was similar to that of the
liposomal transfection reagent at the same dose of siRNA (1 fmol
cell1). Indeed, the dose of siRNA we used was relatively high
compared to other reports [49e54]; however, preliminary results
indicated that lower concentrations of siRNA (0.05e0.2 fmol cell1)
S.Z. Khaled et al. / Biomaterials 87 (2016) 57e68 63did not cause a signiﬁcant reduction of CXCR4 gene expression,
after transfection with the liposomal reagent (data not shown).
2.5.3. siRNA in vivo delivery
In order to evaluate the efﬁcacy of these HNP to deliver siRNA
directed against CXCR4 in vivo, we employed an orthotopic human
breast cancer mouse model. To this aim, MDA-MB-231 cells were
inoculated into the mammary fat pad of female athymic nude mice.
When mouse tumors reached approximately 5 mm diameter, they
were randomly subdivided into three groups (n¼ 10) and treated by
tail vein injections. Mice were treated with: (i) CXCR4 siRNA-loaded
HNP (3.3 pmol siRNA/mg HNP, 92 mg HNP/mouse, 0.3 nmol (5 mg)
siRNA/mouse) resuspended in a sterile 0.9% saline solution; (ii)
sterile 0.9% saline solution; (iii) or SNP and CXCR4 siRNA resus-
pended in sterile 0.9% saline solution, using the same amounts of
nanoparticles and siRNA that were used for the ﬁrst group (92 mg
SNP/mouse, 0.3 nmol [5 mg] siRNA/mouse). The treatments were
repeated 3 and 5 days later and mice were sacriﬁced on day 7.
Western blot analyses of extracts fromhomogenized tumors showed
that siRNA-HNP effectively silenced CXCR4 expression, whereas
CXCR4 expression was not signiﬁcantly lower in tumors of mice
treated with SNP and siRNA than in untreated controls (Fig. 8a).
Moreover, the reduction of CXCR4 expression seemed to be com-
parable with that measured in the cell culture experiments (Fig. 7c).
This suggests that, besides having a good transfection efﬁcacy, the
HNP preferentially accumulated in the tumor. To verify this hy-
pothesis, we analyzed the biodistribution of the HNP and SNP in
thesemousemodels. To this aim, wemeasured the silicon content in
the tumor, heart, lungs, liver, kidney, spleen and peripheral blood of
the three groups of mice using Inductively Coupled PlasmaeAtomic
Emission Spectroscopy. Readings for blood, kidney, spleen and heart
were below the detection limits, while signiﬁcant amounts of silicon
were found in the tumor, lungs, and liver (Fig. 8b). As shown in
Fig. 8b, the level of silicon was 10-fold higher in the tumor of HNP-
treated animals than in those of SNP-treated animals. Moreover, in
SNP-treated mice, the level of siliconwas higher in lungs than in the
tumor. We can argue that HNP bearing polyethylene glycol (PEG)
chains on their surface (Fig. 1a) remained longer in the circulation
than did SNP and thus had a greater chance of penetrating the tumor
microenvironment, as in the case of many PEG-based systems
[55,56]. Indeed, in HNP-treated animals the silicon content was 5-
fold higher in the tumor than in the lung or liver. Taken together,
these data suggest that the in vivo efﬁcacy of gene silencing with
siRNA-HNP was due not only to the latters' endolysosomal escape
but also to their propensity to accumulate at the tumor site.Fig. 8. siRNA-HNP in vivo delivery. (a) Western blot analysis of CXCR4 levels in the tumor of m
The results represent the average of three independent experiments (n ¼ 3) and error bars re
analysis by ICP-AES shows that the HNP target the tumor while the SNP accumulate preva
(n ¼ 4) and error bars represent standard deviations. * ¼ p < 0.05, ** ¼ p < 0.01, *** ¼ p <3. Conclusions
The one-pot synthesis described in this paper is an easy-to-
perform efﬁcient means with which to produce a nanovector able
to deliver a payload in the cytoplasm. The in situ incorporation of a
ﬂuorescent dye within the silica lattice during the synthesis pro-
cedure resulted in the production of inherently pH-responsive
ﬂuorescent nanoparticles that do not require further functionali-
zationwith a ﬂuorescent tag. The basic nature of the tertiary amine-
terminated monomer favored the silane hydrolysis [57] and the
subsequent co-polymerization reaction between the polymer chain
and the silica nanoparticles resulted in a stable and uniform poly-
meric nanolayer with a well dispersed and reproducible composi-
tion. Moreover, the HNP exhibited an increase in thermal stability
when compared to pristine polymer and displayed favorable buff-
ering properties in an acidic environment associated with an
increased hydrodynamic volume. In addition, the tuning of pH-
response by varying the silica:hydrogel ratio enabled the pH-
dependent loading and release of siRNA and facilitated the endo-
somal escape of the nanoparticles through the “proton sponge
effect”.
As demonstrated by the group of Peppas [26,43], PDEAEM has a
pKa of ~7.2, therefore, its buffering properties can exploit the
endosomal acidic environment (pH < 7.2). Thanks to this phe-
nomenon, CXCR4 siRNA was efﬁciently delivered into the cyto-
plasm of MDA-MB-231 breast cancer cells and inhibited the protein
expression of CXCR4 with an efﬁcacy comparable to that of a
commercial transfection reagent [58,59]. Moreover, the HNP
demonstrated an excellent efﬁcacy in delivering siRNA in vivo. In
fact, they preferentially accumulated in the tumors of human breast
cancer-bearing mice and mediated CXCR4 silencing in these tu-
mors. In conclusion, we describe a new synthesis protocol with
which to produce cost-effective and quickly synthesizable nano-
vectors potentially useful as non-viral carriers for siRNA thera-
peutics; this protocol bypasses all the intermediate steps of surface
functionalization that are usually necessary to produce hybrid
particles.
4. Materials and methods
4.1. Chemicals
DEAEM (99%), tetraethylene glycol dimethacrylate (TEGDMA,
90%), N,N,N0,N0-tetraethylmethanediamine (TEMED, 97%), ammo-
nium persulfate (APS, 98% ACS reagent), sodium metabisulﬁteice models of human breast cancer shows a high gene silencing efﬁcacy of siRNA-HNP.
present standard deviations. * ¼ p < 0.05, ** ¼ p < 0.01. (b) Nanoparticle biodistribution
lently in the lung. The results represent the average of four independent experiments
0.005.
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(Mytab), vinyltrimethoxysilane (VTMS, 98%), and (3-aminopropyl)
triethoxysilane (APTES, 99%) were purchased from SigmaeAldrich
(St. Louis, MO). Poly(ethylene glycol)monomethyl ether mono-
methacrylate (PEGMA, Mn ¼ 1000) and ﬂuorescein isothiocyanate
(FITC) were obtained from Polyscience Inc. (Warrington, PA) and
Thermo Scientiﬁc (Thermo Fisher Scientiﬁc Inc., Waltham, MA)
respectively.
4.2. Synthesis of the hybrid nanogel
In-situ polymerization of DEAEM occurs in the presence of
TEGDMA and PEGMA that act as crosslinkers with VTMS monomer
(silica precursor). Synthesis occurred by free radical polymerization
through an oil-in-water emulsion technique. All monomers were
passed through a column of basic alumina powder to remove in-
hibitors before use. 4.5 mL of DEAEM was mixed with 80 mol% of
VTMS and 1 mol% of TEGDMA in a glass ﬂask. The mixture also
contained the polymerizing activator TEMED. To incorporate FITC
into the silica matrix, 1.3 mL of APTES and 16 mg of FITC were
introduced into the same ﬂask. In a separate ﬂask, 5% (w/v) solution
of PEGMA in 100 mL of Millipore (Millipore, Billerica, MA) water
was stirred until it formed a homogeneous solution. 0.4 g of Mytab
and 100 mL of triton X-100 were introduced in the ﬂask while
stirring. The aqueous solution of PEGMA was then mixed with the
monomer mixture into an oil-in-water emulsion. The mixture was
then emulsiﬁed for 5 min using a Misonix probe sonicator (Misonix
S-4000, Qsonica, LLC, Newtown, CT) at 80% amplitude and 60 W
with 15 s pulse on and 15 s pulse off in a pyrex tube which was
partially submerged in a stirred ice water bath. The emulsion was
then purged with nitrogen gas for 20 min to eliminate dissolved
oxygen. Two mol% (with respect to the PDEAEM) of initiator mixer
(APS and NaMBS) in distilled water was added to the reaction
mixture under stirring. The reaction was carried out for 24 h under
continuous agitation in a ﬂask equipped with a mechanical stirrer
(IKA, Staufen, Germany) at 400 rpm at room temperature. The
products were separated from the bulkmixture by centrifugation at
14,000 rpm for 10 min. The particles were then allowed to swell by
introducing 0.5 M HCl solution followed by the addition of acetone
for 10 min, and then centrifuged at 14,000 rpm for 10 min. To
eliminate the surfactants and unreacted monomers, the particles
were washed several times in repeated cycles of resuspension in
acetone and water, and then centrifuged. The particles were then
lyophilized on a Freezone freeze dryer and stored in a desiccator
until use. To obtain particles that differed in the thickness of the
polymer layer, similar experiments were done in parallel with
65 mol% VTMS with respect to the DEAEM monomer.
4.3. SEM and TEM analyses of the nanoparticles
Scanning electron microscopy (SEM) images were acquired
under high vacuum, at 20.00 kV, spot size 3.0e5.0, using a FEI
Quanta 400 FEG ESEM equipped with an ETD (SE) detector (FEI Co.,
Hillsboro, OR). Samples were prepared by introducing 1 drop
(about 2 mL) of aqueous suspension (0.1 mg/mL) of the particles on
the SEM stub (Ted Pella Inc., Redding, CA) and allowing the solvent
to dry in air. Samples were sputter-coated with a 10 nm layer of
gold using a Plasma Sciences CrC-150 sputtering system (Torr In-
ternational Inc., New Windsor, NY) before the analysis. High-
resolution transmission electron microscopy was performed using
a FEI Technai electron microscope (FEI Co.) at a tension of 200 kV.
Samples were prepared by placing 1 drop of 0.1 mg mL1 aqueous
suspension of the hybrid nanogel particles on the 300 mesh
carbon-coated copper grids (Ted Pella) and allowing the solvent to
evaporate in air.4.4. FTIR analyses
Fourier transform infrared (FT-IR) spectra were obtained on a
Nicolet 6700 spectrometer (Thermo Scientiﬁc) with a deuterated
triglycine sulfate (DTGS) detector and potassium bromide (KBr)
beam splitter. Typically, 64 scans were performed in the wave
number range of 4000e600 cm1, both forward and backward at
4 kHz, with a manual gain of one. Pellets of about 10 mg of sample
and 200 mg KBr (spectroscopy grade) (Thermo Scientiﬁc) were
pressed using a Carver laboratory press. Spectra were collected by
transmitting IR light through the pellets.
4.5. XPS analyses
We examined the surface of the hybrid nanogel particles also
using X-ray photoelectron spectroscopy (XPS). XPS measurements
canprobe amaximumsamplingdepth of approximately 3e5nmand
therefore provide information about surface properties. XPS mea-
surementsweremadewith a PHIQuantera XPS (Physical Electronics,
Inc, Chanhassen,MN),which uses a focusedmonochromatic Al KaX-
ray (1486.7 eV) source for excitation. The 40 W, 15 kV and 200 mm
diameter X-rays were used on the sample. The vacuumpressurewas
maintained below 5.0 108 Tor during the analysis. The XPS survey
scan spectra in the 1100.0 eV binding energy rangewere recorded in
0.5 eV steps with a pass energy of 140eV. High resolution scan
spectra of C1s were recorded in 0.1 eV steps with a pass energy of
26 eV. Low energy electrons and Ar þ ions were conducted for
specimen neutralization in each measurement. The spectral lines
were referenced against the C1s signal at 284.50 eV. In spectral
deconvolution, the widths of Gaussian peaks were maintained con-
stant for all components in each spectrum.
4.6. DLS, zeta-potential and pH titration
The hydrodynamic diameters of the hybrid nanoparticles were
characterized using a ZetaPALS Zeta Potential Analyzer with a Multi
Angle Particle Sizing Option installed (Brookhaven Instruments
Corporation, Holtsville, NY), operating with a 25 mW laser at a
wavelength of 660 nm. Scattered light was detected at 90 to the
incident beam. Each sample was subjected to 3 three-minute
measurements. Typically, 2.5 mL suspensions of the hybrid nano-
gel particles in phosphate buffer with physiological ionic strength
(100 mM) at a concentration of 0.1 mg mL1 were used for the
characterization at a temperature of 25 C. Phosphate buffer with a
different pHwas prepared andmeasured with an ISFET probe using
a SevenEasyMettler Toledo pHmeter (Mettler Toledo International,
Greifensee, Switzerland). In a separate experiment, the hybrid
particles (using the same concentration as above) were dispersed in
PB ﬁrst at pH 7 and thenwere centrifuged and redispersed at pH 4;
this cycle was carried out three times and the Dh was measured
after each pH change (see Fig. 3c). The hydrodynamic diameter of
the dispersed particles was measured by density light scattering to
evaluate the reversible pH responsiveness in two different pH en-
vironments. The Zeta-potential was measured by electrophoretic
light scattering using the ZetaPALS Zeta Potential Analyzer (Broo-
khaven Instruments Corporation, Holtsville, NY). 1.4 mL suspension
of the hybrid nanogel particles in PB with an ionic strength of
100 mM with varying pH at a concentration of 0.1 mg mL1 was
used for Zeta-potential characterization. Scattered light was
detected at an angle of 15 and at a temperature of 25 C. Each
sample was subjected to three measurements.
To determine the buffering capacity of the hybrid nanogel par-
ticles in aqueous environment, we examined protonation of the
particles by pH titration. In a typical experiment, 1 mg mL1 sus-
pension of the particles in 20 mL NaCl solution with an ionic
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of 0.1 M NaOH. While the HCl (0.1M) was added stepwise to each
suspension the pHwas measured using a pHmeter (AB15, Accumet
Basic, Fisher Scientiﬁc). The same experiment was done with a
blank solution lacking any particle as a control.
4.7. Thermogravimetric analysis
Thermogravimetric analysis (TGA) of hybrid nanogels, pristine
polymer and bare silica particles was performed after these sam-
ples (~16.0mg) were dried under vacuum at 40 C for 24 h. TGAwas
performed using a Q600 SDT (TA Instruments Inc., New Castle, DE)
by heating the particles from 30 C to 700 C in nitrogen atmo-
sphere at a rate of 20 C min1.
4.8. Loading and release of siRNA
A Cy3-labeled reporter siRNA (Ambion, Thermo Fisher Scientiﬁc
Inc.) was used to determine the pH-mediated loading and release
kinetics of the HNP system. Polyplexes were formed by mixing
5 nmol of Cy3-labeled siRNA with the HNP at an amino/phosphate
(N/P) ratio of 40 in PB solutions at a pH of 6 or 7.4. In a typical
procedure, a 100 mL aliquot of 300 mg HNP were mixed with 100 mL
aliquot of 0.3325 mg siRNA in PB solution. The mix was gently
shaken at room temperature for 15 min. The resulting mixture was
left at room temperature for another 15 min. The solution was then
spun down at 21,000 g for 5 min. The loading was evaluated by
analyzing the ﬂuorescence intensity of the supernatant with a
spectroﬂuorimeter. Standard procedures were followed to prepare
the PB solution with a certain pH before the complex formation. To
investigate the pH-mediated release of siRNA, the siRNA-HNP
complexes loaded at pH 7 were incubated in PB solution at pH 6
or 7.4. The amount of siRNA released was monitored by evaluating
Cy3 ﬂuorescence intensity with a spectroﬂuorimeter.
4.9. Cell cultures
The cells used in this study were from the human “triple-
negative” breast cancer cell line MDA-MB-231 (ATCC# HTB-26, LGC
Standards, Teddington, Middlesex, UK). They were cultured at 37 C
and 5% CO2 in DMEM (Thermo Scientiﬁc) culture medium sup-
plemented with 10% (v/v) FBS and 1% (v/v) penicillin-streptomycin
solution (Thermo Scientiﬁc).
4.10. MTT assay
Cells were seeded in 96-well microplates (Costar, Corning Inc.,
Corning, NY) at a density of 25  103. Twenty-four hours after cell
attachment, plates were washed with PBS, and the cells were
treated with increasing concentrations, from 0.1 to 2 ng cell1, of
both SNP and HNP for 3 or 24 h. Six replicate wells were used for
each control and tested concentration. The tetrazolium salt (MTT
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide])
was dissolved in PBS (5 mg/mL) and added to MDA-MB-231 cells
(100 mLmL1 DMEMwithout serum or phenol red) according to the
method of Mosmann [60]. After incubation for 3 h at 37 C, a so-
lution of 1 N hydrogen chloride-isopropanol (1:24, v:v) was
pipetted to each well, and mixed to dissolve the dark-blue for-
mazan crystals formed. After a few minutes at room temperature,
the plates were read at 570 nm in a BioTek Microplate reader.
4.11. Neutral red uptake assay
Human breast cancer MDA-MB-231 cells were seeded as
described above and treated with SNP or HNP and exposed to amedium (without serum or phenol red) containing 50 mg mL1
neutral red dye and processed according to the method of Boren-
freund and Puerner [61]. After incubation for 3 h at 37 C, cells were
washed twice in PBS and ﬁxed according to the procedure
described by Riddell et al. [62]. The plates were then left at room
temperature for 10 min, and the absorbance of the released neutral
red dye was read at 540 nm in a BioTek Microplate reader (BioTek
Instruments, Winooski, VT).
4.12. TEM analyses of cells
For TEM analyses N 105 MDA-MB-231 cells were seeded in
eachwell of a 6-well plate. The next day, the cells were treated with
0.3 ng cell1 of HNP or SNP. Untreated cells were used as a control.
Three hours after the treatment, the cells were washed and ﬁxed in
a solution of 2% (w/v) paraformaldehyde (Electron Microscopy
Sciences; Hatﬁeld, PA) and 3% (w/v) glutaraldehyde (Sigma-
eAldrich) in 0.01 M phosphate buffered saline pH 7.4 (2 mL well1;
SigmaeAldrich) for one hour. Fixed samples were washed in 0.1 M
cacodylate buffer and treated with 0.1% Millipore-ﬁltered buffered
tannic acid, postﬁxed with 1% buffered osmium tetroxide for
30 min, and stained en bloc with aqueous 1% Millipore-ﬁltered
uranyl acetate. The samples were washed several times in water,
then dehydrated in increasing concentrations of ethanol, inﬁl-
trated, and embedded in LX-112 medium. The samples were poly-
merized in a 60 C oven for about 3 days. Ultrathin sections were
cut in a Leica Ultracut microtome (Leica, Deerﬁeld, IL), stained with
uranyl acetate and lead citrate in a Leica EM Stainer, and examined
in a JEM 1010 transmission electron microscope (JEOL, USA, Inc.,
Peabody, MA) at an accelerating voltage of 80 kV at High Resolution
Electron Microscopy Facility at the University of Texas MD Ander-
son Cancer Center. Digital images were obtained using AMT Im-
aging System (Advanced Microscopy Techniques Corp, Danvers,
MA).
4.13. Evaluation of siRNA delivery through ﬂuorescence microscopy
2 104MDA-MB-231 cells were seeded in eachwell of a 96-well
plate. The next day, cells were either transfected with siRNA using
the HiPerFect transfection reagent (Qiagen, Hilden, Germany) or
treated with siRNA-loaded hybrid nanoparticles. The siRNA was
“Cy3-Labeled Negative Control siRNA” (Life Technologies, Thermo
Fisher Scientiﬁc Inc.). For transfection, we used 1 pmol siRNA and
1 mL HiPerfect reagent in a ﬁnal volume of 200 mL culture medium
per well. Hybrid nanoparticles were loaded by using 0.16 pmol
siRNA mg1 HNP in PB buffer at pH 6, then they were washed twice
in PB buffer at pH 7.4 and resuspended in the cell medium. 6 mg
HNP per well were used in a ﬁnal volume of 200 mL culture me-
dium. After 3 h cells treated with the HNP were washed twice with
PBS and the fresh culture medium was added. Twenty-four hours
later cells were washed twice with PBS and supplemented with
fresh culture medium. All experiments were performed in four
replicates. The cells were observed with a Nikon ﬂuorescence mi-
croscope using a 10 lens, and the images were acquired. Images
were analyzed by using “NIS elements” (Nikon) and “ImageJ”
(NCBI) softwares. To evaluate ﬂuorescence intensity, four different
ﬁelds of view were acquired from each well.
4.14. CXCR4 silencing
For the evaluation of gene silencing through real-time RT-PCR,
1.2  105 MDA-MB-231 cells were seeded in each well of a 12-well
plate. The next day, cells were either transfected with siRNA by
using the HiPerFect transfection reagent (Qiagen) or treated with
siRNA-loaded HNP. We used a cocktail (1:1 ratio) of two types of
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against two different regions of the CXCR4 transcript. For the
transfection with the reagent we used 120 pmol siRNA and 6 mL
HiPerfect reagent in a ﬁnal volume of 1.2 mL culture medium per
well. The HNPwere loaded by using 3.3 pmol siRNA mg1 HNP in PB
buffer at pH 6, then they were washed twice in PB buffer at pH 7.4
and resuspended in the cell medium. 36 mg HNP per well were used
in a ﬁnal volume of 1.2 mL culture medium. Every experiment was
performed in 3 independent replicates.
To measure the reduction of the CXCR4 protein, 2.4  105 MDA-
MB-231 cells were seeded in each well of a 6-well plate. The next
day, cells were either transfectedwith siRNA by using the HiPerFect
transfection reagent (Qiagen) or treated with siRNA-loaded HNP.
For the transfection we used 240 pmol siRNA and 12 mL HiPerfect
reagent in a ﬁnal volume of 2.4 mL culture medium per well. The
HNPwere loaded by using 3.3 pmol siRNA mg1 HNP and 72 mg HNP
per well in a ﬁnal volume of 2.4 mL culture medium. Each experi-
ment was performed in 3 independent replicates.
4.15. Real time RT-qPCR analyses
Fortyeeight hours after transfection and treatments, total RNA
was extracted from cells with the RNeasy Mini Kit (Qiagen). cDNA
was obtained through retrotranscription of 0.8 mg RNA by using
Superscript II (Life Technologies) as reverse transcriptase and Oli-
go(dT) (Life Technologies) as primers. Real-time qPCR analysis was
performed by using the StepOnePlus System (Life Technologies) as
real-time thermal cycler, TaqMan Gene Expression Assays and
TaqMan Gene Expression Master Mix. In particular, CXCR4 tran-
script levels were evaluated using, the TaqMan Gene Expression
Assay CXCR4 Hs00607978_s1 (Life Technologies) and normalized
using TaqMan Gene Expression Assay GAPDH Hs02758991_g1 (Life
Technologies). The analysis was performed in triplicate for each
biological replicate. Relative quantiﬁcation of CXCR4 gene was ob-
tained from averages of threshold cycle (Ct) using the 2DDCt
method [63]. Statistical signiﬁcance was assessed by one-way two-
tail paired T-test.
4.16. Cell lysis, protein extraction and western blot analysis
Fortyeeight hours after transfection, whole cell protein extracts
were obtained by cell lysis using RIPA buffer (Thermo Scientiﬁc)
with 1 mL Halt protease inhibitor cocktail (Thermo Scientiﬁc) per
100 mL of buffer. 40 mg of whole cell protein extracts were loaded
onto SDS/PAGE and then transferred on to a PVDF membrane for
Western blot analysis, as previously described [64]. Blots were
incubatedwith rabbit anti-CXCR4 (Millipore) and rabbit anti-GAPDH
(Abcam, Cambridge, UK) primary antibodies and then with horse-
radish peroxidase-conjugated anti-Rabbit IgG (SigmaeAldrich) as
secondary antibody. The bands were revealed with the SuperSignal
West Dura Chemiluminescent Substrate (Thermo Scientiﬁc) and
images were visualized and acquired with the ChemiDoc
XRS þ System and Image Lab software (Bio-Rad Laboratories, Her-
cules, CA). Quantitative analysis of the bands was performed by
using ImageJ software (NIH) and CXCR4 signals were normalized
with GAPDH. The reported results are the average of three (n ¼ 3)
independent experiments. Statistical signiﬁcance was assessed by
one-way two-tail paired T-test.
4.17. Mice models of human breast cancer
Female athymic nude mice (NCr-Fox1nu; 6e8 week old) were
purchased from Charles Rivers Laboratories (Wilmington, MA) and
maintained as previously described) [65]. Orthotopic breast cancer
models were established by implanting 2  106 MDA-MB231 cellsin the mouse mammary fat pad. Experiments were performed in
conformity with protocols approved by the Veterinary Department
of the Italian Ministry of Health and in accordance with the ethical
and safety rules, and guidelines for the use of animals in biomedical
research provided by the relevant Italian laws and by European
Union directive no. 2010/63/EU. All efforts were made to minimize
animal suffering.
4.18. In vivo delivery of siRNA-HNP
Tumor-bearing mice were selected for treatment when the tu-
mors reached approximately ~5 mm in diameter as measured with
a digital caliper (14e21 days post-inoculation). These mice were
randomly distributed in 3 groups (n ¼ 10 per group). Prior to
treatments, each mouse was anesthetized, and 100 mL of sterile
0.9% saline solution containing CXCR4 siRNA-loaded HNP were
then injected intravenously via the tail vein. In particular, for each
dose, 92 mg HNP were loaded with 0.3 nmol (5 mg) siRNA (3.3 pmol
siRNA mg1 HNP). In the sham experiments, mice were injected
with 100 mL of sterile 0.9% saline solution. Finally, treatment of the
third group consisted in the injection of 100 uL of sterile 0.9% saline
solution containing 92 mg SNP incubated with 0.3 nmol (5 mg)
siRNA. Treatments were repeated 3 and 5 days later. Mice were
sacriﬁced on day 7 and tumor samples were collected for protein
extraction and expression analysis.
4.19. Western blot analysis of CXCR4 levels in tumor mice models
An appropriate volume (1 ml of buffer for 10mg of tissue) of ice-
cold homogenizer buffer (T-PER Tissue Protein Extraction Reagent,
Thermo Scientiﬁc, Rockford, IL, USA) containing protease inhibitors
(Thermo Scientiﬁc) was pipetted into pre-chilled homogenization
tubes. The tumors were rinsed in cold PBS to remove blood, cut in
small pieces and transferred into the tubes. Then, they were ho-
mogenized using a tissue homogenizer (Bio-Gen PRO200, PRO
scientiﬁc) following the protocol supplied by themanufacturer. The
homogenate was transferred to a 2 mL centrifuge tube, incubated
on ice for 15 min and then centrifuged at maximum speed
(16,100 g) for 30 min. The supernatant was collected in a clean tube
and protein concentration was checked by Bradford assay using
albumin as standard. 50 mg of whole cell protein extracts were
loaded onto 12% (w/v) polyacrylamide gel and then transferred on
to a PVDF membrane for Western blot analysis, as previously
described. Blots were incubated with rabbit anti-CXCR4 (Millipore)
and rabbit anti-GAPDH (Abcam) primary antibodies and then with
horseradish peroxidase-conjugated anti-Rabbit IgG (Sigma-
eAldrich) as secondary antibody. The bands were revealedwith the
SuperSignal West Dura Chemiluminescent Substrate (Thermo Sci-
entiﬁc) and images were visualized and acquired with the Chem-
iDoc XRS þ System and Image Lab software (Bio-Rad Laboratories,
Hercules, CA). Quantitative analysis of the bands was perfomed
using ImageJ software. The reported results are the average of tu-
mor analyses from three (n ¼ 3) different mice for each treatment
group. Statistical signiﬁcance was assessed by one-way two-tail
paired T-test.
4.20. Analysis of HNP biodistribution by ICP-AES
For Inductively Coupled PlasmaeAtomic Emission Spectroscopy
(ICP-AES) analysis, organs (tumor, heart, lungs, liver, kidneys, and
spleen) were harvested, washed in PBS, weighed and homogenized.
They were then centrifuged at 5000 rpm for 20 min and superna-
tant was collected, ﬁltered using 0.45 mm nylon centrifugal ﬁlter
microfuge tubes (VWR), and diluted with DI water for elemental
analysis by ICP-OES (Varian 720 ES, Varian Inc., Walnut Creek, CA)
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average from analysis of tumors of four (n ¼ 4) different mice for
each treatment group. Statistical signiﬁcance was assessed by one-
way two-tail unpaired T-test.
4.21. Statistical analyses
All the numeric data are averages of the results of a minimum of
three independent experiments. Statistical computation was per-
formed with GraphPad Prism software (GraphPad Software, Inc., La
Jolla, CA) or Microsoft Excel software (Microsoft, Redmond, WA).
The statistical signiﬁcance was calculated using paired or unpaired
one-way two-tail Student's T-test.
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